What are the pharmacy supervision changes?
The Human Medicines (Authorisation by Pharmacists and Supervision by Pharmacy Technicians) Order 2025 followed draft legislation published by the Department of Health and Social Care in July 2025. That draft itself followed consultation on proposals to amend the Medicines Act 1968 and the Human Medicines Regulations 2012. Parliament and the Privy Council approved the Order, and the GPhC confirmed the commencement arrangements in a statement published on 12 December 2025.
It takes effect in two phases, separated by a one-year transition period. The transition exists so the GPhC and the professional leadership bodies can develop and publish supporting standards and guidance. The first phase commenced on 7 January 2026 and has been operating for some months. The second commences on 10 December 2026 — about four and a half months away at the time of writing — and remains conditional on the publication of standards which do not yet exist.
The stated purpose, in the regulator's language, is to enable pharmacists to deliver more patient-facing clinical services while pharmacy technicians maximise their contribution through effective use of their skills and expertise. Whether the reforms achieve that depends heavily on arrangements which have not been settled. The later sections of this guide cover them.
Can staff hand out prescriptions when the pharmacist is absent?
Yes. Pharmacists became able to authorise the handing out of checked and bagged prescriptions when the pharmacist is absent or treated as absent. That is the whole of the first phase. Its narrowness, against the surrounding commentary, is worth stating plainly.
One point of precision is worth recording, because much of the coverage obscured it. The GPhC's published position is that a pharmacist may authorise any member of pharmacy staff to hand out checked and bagged prescriptions in the pharmacist's absence — not pharmacy technicians alone. Reporting at the time framed the change in terms of pharmacy technicians. That is accurate as a description of who will ordinarily be authorised, and inaccurate as a description of what the legislation permits.
Two further matters settle the operational position. The Royal College of Pharmacy published guidance on authorisation by a pharmacist for checked and bagged prescriptions — the appropriate reference for how the arrangement should be operated. And Community Pharmacy England confirmed in December 2025 that the change is available to NHS community pharmacies without any amendment to the Terms of Service under the 2013 Regulations. That removed a question a number of contractors had raised.
The practical effect within a community pharmacy is modest and real. A patient collecting a prescription which a pharmacist has already checked and bagged need no longer be turned away because the pharmacist has stepped out. That fixes a recurring frustration for patients and a recurring inefficiency for pharmacies, without altering who performed the clinical check or when.
Can pharmacy technicians dispense without a pharmacist from December 2026?
The second phase is materially more substantial. It contains two provisions.
First, pharmacists will be able to authorise a pharmacy technician to undertake or supervise the preparation, assembly, dispensing and sale and supply of medicines which would otherwise need a pharmacist to perform or supervise them. Second, pharmacy technicians will be able to take primary responsibility for the preparation and assembly of medicinal products in hospital aseptic facilities, under Regulation 4A of the Human Medicines Regulations 2012.
Both provisions are conditional. The GPhC, the Pharmaceutical Society of Northern Ireland and the professional leadership bodies must publish supporting professional standards and guidance before they take effect. That is what the transition period is for — and it introduces the timing question examined below.
The change of legal architecture is worth noting in its own right. The existing framework requires certain activities to be performed by a pharmacist or under a pharmacist's supervision, with supervision understood as a contemporaneous professional relationship. The new provision permits a pharmacist to authorise a pharmacy technician to undertake or supervise those activities. That separates the activity from the pharmacist's immediate presence and moves the pharmacist's contribution into the authorisation decision. It is a different mechanism, not a relaxed version of the existing one — and it is why the accompanying governance arrangements carry so much weight.
Do you still need a responsible pharmacist?
These reforms are often discussed as though they let pharmacies operate without pharmacists. They do not. The GPhC's published position addresses four matters directly. The legislation does not alter the requirement for a Responsible Pharmacist to be on duty at each registered pharmacy. It does not permit a pharmacy technician to perform the role of Responsible Pharmacist. It is not intended to allow the Responsible Pharmacist to be absent from the pharmacy for longer than two hours. And it does not permit the Responsible Pharmacist to supervise pharmacy staff remotely. Those four propositions dispose of most of what the reforms are popularly supposed to have done. What has changed is what may be delegated, by authorisation, while a Responsible Pharmacist remains in post and present within the ordinary limits. What has not changed is the existence of that post, its occupancy by a pharmacist, or the expectation that the pharmacist is generally there.
An operator planning around the reforms should therefore treat them as altering the division of labour within a pharmacy, not its staffing model. A business case built on reduced pharmacist hours misreads both the legislation and the regulator's stated position. It would also be built on standards which are not yet published.
When will the GPhC publish the new standards?
The second phase depends on supporting standards and rules. Their development has taken longer than the transition period comfortably allows.
The GPhC Council agreed on 11 December 2025 to consult on proposed standards for Superintendent Pharmacists and Responsible Pharmacists, together with Rules for Responsible Pharmacists. The package is intended to clarify and strengthen the organisational governance arrangements for registered pharmacies. The consultation ran from 17 December 2025 to 25 March 2026 and attracted 411 responses: 404 through the survey and seven submitted more generally by individuals and organisations.
Having considered that feedback, the regulator indicated that certain matters need additional consideration and clarification before the standards and rules can be finalised. Some points may be better addressed in supporting guidance than in standards intended to be high level and outcome focused. A final draft is to be brought to a Council meeting scheduled for 5 October 2026, and the standards and rules must be published before the second phase commences on 10 December 2026.
The arithmetic of that timetable deserves attention from anyone planning implementation. Standards approved in early October and published after that leave weeks, not months, between publication and commencement. In that window pharmacies must read them, revise procedures, train staff and settle authorisation arrangements. A pharmacy which intends to use the second phase from December should therefore prepare the elements which do not depend on the standards now, so the remaining work is adaptation rather than construction.
How does a pharmacist authorise a pharmacy technician?
The legislation operates through authorisation by a pharmacist, and the word carries more weight than its brevity suggests.
Authorisation implies a decision about a particular individual and a particular scope, made by a pharmacist who is accountable for making it. It is not a permission attaching automatically to a job title. That construction raises questions the forthcoming standards and rules are expected to address: how an authorisation is recorded, how its scope is expressed, how competence is assured before it is given, how it is reviewed, and how it is withdrawn where circumstances change.
Until those questions are answered, a pharmacy can still settle the matters plainly within its own control. Who would be authorised, and on what evidence of competence. What the scope would be, expressed by activity rather than by generality. Who within the organisation may authorise — the Responsible Pharmacist on duty, the Superintendent, or both in different respects. And how the arrangement would be recorded, so an inspector reconstructing a supply could establish who was authorised to do what, and when.
Those four questions are the substance of implementation. None of them needs the standards to be published before it can be considered.
What are the new superintendent pharmacist standards?
The reforms come with a strengthened governance framework, not a relaxed one. It is a pattern this library has observed in other recent changes.
The GPhC has described its work as introducing new regulatory standards for Superintendent Pharmacists and Responsible Pharmacists, together with Rules for Responsible Pharmacists, specifically to clarify and strengthen organisational governance arrangements for registered pharmacies. That is a considerable development in its own right. The superintendent role has historically been defined more by statute and custom than by a dedicated set of regulatory standards. A pharmacy reading only the supervision provisions will meet the governance requirements as a surprise.
The practical consequence resembles the one identified in the hub and spoke thematic review: the regulator's attention concentrated not on the permitted activity but on whether governance kept pace with it. Pharmacies intending to use the second phase should expect the same question. The standards being developed indicate in advance what form it will take.
Why do some pharmacists oppose the supervision changes?
The reforms are supported and contested along lines worth understanding. Both positions bear on how a pharmacy should implement them.
Community Pharmacy England's director of legal welcomed the changes as improving the extent of care patients receive, reducing delays in accessing medicines and improving access to services. The framing: a step toward bringing care closer to communities, consistent with the ten-year health plan.
The Pharmacists' Defence Association has supported modernisation while maintaining that role clarity and professional identity are non-negotiable. It has argued a specific point which merits attention. Preparation, assembly, sale and supply may now be separated from the clinical check, and the legislation creates additional requirements around pharmacy technician authorisation. On that basis, the association contends that the single set of standards previously applied to both pharmacists and pharmacy technicians should be replaced by two separate and distinct sets, citing the recommendations of the Leng Review in support.
That argument identifies something real, wherever a reader lands on it. Where two professions may perform overlapping activities under different accountabilities, the standards distinguishing them do practical work. A pharmacy implementing the second phase will meet the same question internally when it decides what an authorised technician does, what remains with the pharmacist, and how each is held to account.
A related development supports the point. The GPhC has raised the minimum level of study within its new training standards for pharmacy technicians. It attributes the change to the widening scope of the role — including the introduction of patient group directions permitting technicians to administer and supply certain medicines, and the forthcoming legislation enabling them to take responsibility for dispensing and supplying without pharmacist supervision.
How should a pharmacy prepare for 10 December 2026?
Five matters can be addressed now, before the standards are published. Doing so converts the post-publication period from construction into adaptation.
Establish the current position honestly. Which activities currently require pharmacist performance or supervision in this pharmacy, and where does the constraint actually bind? A pharmacy which has not identified that will delegate the wrong things.
Assess the technician workforce. Registration status, competence, experience and the training which would be required. Remember the regulator has raised the minimum level of study for future entrants, and existing team members will vary considerably.
Draft the authorisation architecture. Who authorises, on what evidence, in what scope, recorded how, reviewed when, withdrawn by whom. Expect to revise it once the standards appear — revising a draft is considerably faster than producing one.
Identify the procedures which will require amendment. The dispensing procedures, the responsible pharmacist procedures and the training records will each be affected. Our SOP guide covers the discipline which keeps that work manageable rather than becoming a rewrite.
Decide whether to use the second phase at all. It is a permission, not a requirement. A pharmacy whose constraint is demand rather than pharmacist availability may gain little while acquiring governance obligations. That decision is legitimate, should be taken deliberately, and should be recorded.
Do the supervision changes apply in Scotland, Wales and Northern Ireland?
The Order is Great Britain legislation. The professional standards which condition the second phase are being developed by the GPhC for Great Britain and by the Pharmaceutical Society of Northern Ireland for Northern Ireland. Operators working across those jurisdictions should expect the professional framework, and potentially its timing, to differ even where the underlying legislative change corresponds. Rely on the guidance issued by the regulator for the jurisdiction in which the pharmacy is registered.
Key takeaways
- The 2025 Order takes effect in two phases: the first has operated since 7 January 2026, and the second commences 10 December 2026 after a one-year transition period.
- The first phase permits a pharmacist to authorise the handing out of checked and bagged prescriptions during absence. The GPhC's position is that any member of pharmacy staff may be authorised, not pharmacy technicians alone.
- The second phase permits authorisation of a pharmacy technician to undertake or supervise preparation, assembly, dispensing and sale and supply. It also permits primary responsibility for preparation and assembly in hospital aseptic facilities.
- The Responsible Pharmacist requirement is unchanged, a technician may not perform that role, absence beyond two hours is not intended, and remote supervision is not permitted.
- The supporting standards remain unpublished: 411 consultation responses received, a final draft due at Council on 5 October 2026, publication required before 10 December. That leaves weeks rather than months for implementation.
- Authorisation implies a decision about an individual and a scope, not a permission attaching to a job title. Four questions — who, what, recorded how, reviewed when — can be settled before the standards appear.
- The reforms arrive alongside strengthened governance standards for Superintendent and Responsible Pharmacists. The second phase is a permission rather than a requirement, and a pharmacy may decline it deliberately.
Sources and further reading
FAQs
Who was authorised, to do what.
Authorisation is a records question before it is a staffing one. An inspector reconstructing a supply will ask who was authorised to do what, by whom, and when. Dataforge PMR attributes each step of a dispensing journey to the person who performed it — the foundation the December arrangements will be built on.
See Dataforge PMR